Illumina Inc
USUSDIllumina Inc (US:ILMN) — Medical Specialities. Количество бирж, на которых торгуются акции компании: 2. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.
О компании
- Сайт
- illumina.com
- Сектор
- Health Care · Medical Specialities
- Штаб-квартира
- San Diego, United States
- Сотрудники
- 9 250
- Основана
- 1998
- Акций в обращении
- 151 млн на 2026-07-24
- Свободное обращение
- 149.78 млн
- Рыночная капитализация
- 41.33 млрд USD
- Инсайдеры
- 0.21%
- Институциональные инвесторы
- 106.47%
- Отрасль (SIC)
- Laboratory Analytical Instruments
- ISIN
- US4523271090
- LEI
- SQ95QG8SR5Q56LSNF682
Описание
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Дивиденды
| Экс-дата | Выплата | Сумма | % | Тип | Тикер |
|---|---|---|---|---|---|
| 2024-06-25 | — | 3.1051 USD | 1.1/1.1 % | — | LSE:0J8Z |
Новости этой недели
Пресс-релизы с сайта для инвесторов компании, обновляемые ежедневно. Ссылки ведут на сайт компании. Заголовки написаны на оригинальном языке, как и на сайте компании.
Крупнейшие держатели
| Держатель | Доля | Акции | Дата отчета |
|---|---|---|---|
| Blackrock Inc. | 12.71% | 19.19 млн | 2026-06-30 |
| Capital World Investors | 10.22% | 15.43 млн | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.39% | 6.63 млн | 2026-06-30 |
| Vanguard Capital Managem… | 4.36% | 6.59 млн | 2026-06-30 |
| State Street Corporation | 4.31% | 6.51 млн | 2026-06-30 |
| WCM Investment Managemen… | 4.11% | 6.21 млн | 2026-06-30 |
| iShares Trust-iShares Co… | 3.51% | 5.3 млн | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 3.02% | 4.56 млн | 2026-06-30 |
| FMR, LLC | 3% | 4.52 млн | 2026-06-30 |
| AQR Capital Management,… | 2.35% | 3.54 млн | 2026-06-30 |
| Primecap Management Comp… | 2.33% | 3.51 млн | 2026-06-30 |
| AMERICAN BALANCED FUND | 2.31% | 3.49 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.18% | 3.3 млн | 2026-06-30 |
| Geode Capital Management… | 1.95% | 2.95 млн | 2026-06-30 |
| Growth Fund of America | 1.82% | 2.74 млн | 2026-06-30 |
| New Economy Fund | 1.78% | 2.68 млн | 2026-06-30 |
| VANGUARD HORIZON FUNDS-V… | 1.17% | 1.76 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.15% | 1.74 млн | 2026-06-30 |
| WASHINGTON MUTUAL INVEST… | 1.04% | 1.57 млн | 2026-07-31 |
| NEW PERSPECTIVE FUND | 0.93% | 1.4 млн | 2026-06-30 |
| THAYSEN JACOB (Chief Exe… | ≈0.07% | 109 073 | 2026-03-05 |
| CUNNINGHAM EVERETT V (Of… | ≈0.03% | 50 840 | 2025-03-05 |
| BARNARD STEVEN (Chief Te… | ≈0.03% | 41 335 | 2026-03-05 |
| DHINGRA ANKUR (Chief Fin… | ≈0.02% | 34 264 | 2026-03-05 |
| PEGELS KEVIN CARL (Offic… | ≈0.02% | 29 038 | 2026-03-05 |
| SCHILLER PHILIP W (Direc… | ≈0.01% | 22 220 | 2026-05-21 |
| EPSTEIN ROBERT S (Direct… | ≈0.01% | 22 139 | 2025-05-21 |
| LECKMAN PATRICIA L (Offi… | ≈0.01% | 21 259 | 2026-06-05 |
| ARNOLD FRANCES H PH.D. (… | ≈0.01% | 20 907 | 2025-05-21 |
| MEISTER KEITH A (Directo… | — | — | 2026-09-04 |
